ATAI LIFE SCIENCES NV (9VC.DE) Stock Price, Forecast & Analysis
Europe - FRA:9VC - NL0015000DX5 - Common Stock
9VC.DE Key Statistics, Chart & Performance
The current stock price of 9VC.DE is 3.703 EUR. In the past month the price decreased by -22.04%. In the past year, price increased by 261.27%.
9VC.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1SAN.MI | SANOFI | 11.48 | 212.63B | ||
| SAN.PA | SANOFI | 11.24 | 208.22B | ||
| SNW.DE | SANOFI | 11.25 | 208.42B | ||
| 1MRK.MI | MERCK KGAA | 13.35 | 49.41B | ||
| MRK.DE | MERCK KGAA | 12.86 | 47.59B | ||
| UCB.BR | UCB SA | 35.31 | 44.10B | ||
| BAYN.DE | BAYER AG-REG | 5.2 | 25.60B | ||
| 1BAYN.MI | BAYER AG-REG | 5.28 | 26.00B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 25.24 | 10.40B | ||
| IPN.PA | IPSEN | 12.05 | 10.38B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 97.84 | 9.06B | ||
| VIRP.PA | VIRBAC SA | 19.93 | 2.90B |
Related stock screener links
About 9VC.DE
Company Profile
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. The company is headquartered in Amstelveen, Noord-Holland and currently employs 54 full-time employees. The company went IPO on 2021-06-18. The firm focused on developing treatments for mental health disorders. The firm's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
Company Info
ATAI LIFE SCIENCES NV
Prof. J.H.Bavincklaan 7
Amstelveen NOORD-HOLLAND NL
Employees: 54
Phone: 31207932536
ATAI LIFE SCIENCES NV / 9VC.DE FAQ
What does ATAI LIFE SCIENCES NV do?
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company. The company is headquartered in Amstelveen, Noord-Holland and currently employs 54 full-time employees. The company went IPO on 2021-06-18. The firm focused on developing treatments for mental health disorders. The firm's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
What is the stock price of ATAI LIFE SCIENCES NV today?
The current stock price of 9VC.DE is 3.703 EUR. The price decreased by -14.62% in the last trading session.
Does 9VC stock pay dividends?
9VC.DE does not pay a dividend.
What is the ChartMill rating of ATAI LIFE SCIENCES NV stock?
9VC.DE has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Would investing in ATAI LIFE SCIENCES NV be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 9VC.DE.
Is ATAI LIFE SCIENCES NV (9VC.DE) expected to grow?
The Revenue of ATAI LIFE SCIENCES NV (9VC.DE) is expected to grow by 355.42% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is the next earnings date for 9VC stock?
ATAI LIFE SCIENCES NV (9VC.DE) will report earnings on 2025-11-11, before the market open.
9VC.DE Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to 9VC.DE. When comparing the yearly performance of all stocks, 9VC.DE is one of the better performing stocks in the market, outperforming 99.16% of all stocks.
9VC.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to 9VC.DE. 9VC.DE has a great financial health rating, but its profitability evaluates not so good.
9VC.DE Financial Highlights
Over the last trailing twelve months 9VC.DE reported a non-GAAP Earnings per Share(EPS) of -0.6. The EPS decreased by -72.5% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -78.89% | ||
| ROE | -103.85% | ||
| Debt/Equity | 0 |
9VC.DE Forecast & Estimates
15 analysts have analysed 9VC.DE and the average price target is 10.65 EUR. This implies a price increase of 187.7% is expected in the next year compared to the current price of 3.703.
For the next year, analysts expect an EPS growth of 46.81% and a revenue growth 355.42% for 9VC.DE